Literature DB >> 9027662

Urinary 1 beta-hydroxyursodeoxycholic acid during ursodeoxycholic acid therapy.

R Yamakawa, A Kimura, K Aoki, M Suzuki, R Mahara, M Tohma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9027662     DOI： 10.1007/bf02358625

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  3 in total

1.  Synthesis of the 1 beta-hydroxylated bile acids, unusual bile acids in human biological fluids.

Authors:  M Tohma; R Mahara; H Takeshita; T Kurosawa; S Ikegawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-07       Impact factor: 1.645

2.  Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid.

Authors:  B J Koopman; B G Wolthers; J C van der Molen; G T Nagel; W Kruizinga
Journal:  Biochim Biophys Acta       Date:  1987-02-14

3.  Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment.

Authors:  A K Batta; R Arora; G Salen; G S Tint; D Eskreis; S Katz
Journal:  J Lipid Res       Date:  1989-12       Impact factor: 5.922
  3 in total
  1 in total

1.  A new, major C27 biliary bile acid in the red-winged tinamou (Rhynchotus rufescens):25R-1beta, 3alpha,7alpha-trihydroxy-5beta-cholestan-27-oic acid.

Authors:  Lee R Hagey; Genta Kakiyama; Akina Muto; Takashi Iida; Kumiko Mushiake; Takaaki Goto; Nariyasu Mano; Junichi Goto; Cleida A Oliveira; Alan F Hofmann
Journal:  J Lipid Res       Date:  2008-11-14       Impact factor: 5.922
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.